Privia Health (PRVA) announces passing of Director Patricia Maryland

Privia Health Group, Inc. (PRVA) reported the passing of Board member Patricia Maryland on October 24, 2025.

Accepted by SEC EDGAR 10/28/2025 - 05:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Privia Health Group, Inc. (PRVA) reported the passing of Board member Patricia Maryland on October 24, 2025. She served on the Board for five years and was Chair of the Compliance Committee. The company expressed gratitude for her service and contributions.

The report is filed under Item 8.01 (Other Events) and was signed by Chief Executive Officer Parth Mehrotra. No additional board or committee actions are described in this disclosure.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Privia Health (PRVA) announce in this 8-K?

The company reported the passing of Board member Patricia Maryland on October 24, 2025.

What roles did Patricia Maryland hold at PRVA?

She was a member of the Board of Directors and Chair of the Compliance Committee.

Does the 8-K detail further board or committee changes for PRVA?

No additional changes are described in this disclosure.

Under which item was the event reported for PRVA?

It was reported under Item 8.01 (Other Events).

Who signed the PRVA 8-K and when?

It was signed by Chief Executive Officer Parth Mehrotra on October 28, 2025.

What exchange lists PRVA and what class of securities?

PRVA’s Common Stock is listed on the Nasdaq Global Select Market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

0001759655FALSE00017596552025-10-242025-10-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

FORM 8-K

_______________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 24, 2025

_________________________

Privia Health Group, Inc.

(Exact Name of Registrant as Specified in Its Charter)

_________________________

Delaware						001-40365			81-3599420
(State or other jurisdiction of incorporation or organization)						(Commission File No.)			(I.R.S. Employer Identification No.)
950 N. Glebe Rd.,
Suite 700
Arlington,			Virginia						22203
(Address of Principal Executive Offices)									(Zip Code)

(571) 366-8850

Registrant's telephone number, including area code

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $0.01 par value per share			PRVA			The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On October 24, 2025, Patricia Maryland, a member of the Board of Directors of Privia Health Group, Inc. (the “Company”) and Chair of its Compliance Committee, passed away. The Company is saddened by her death and grateful for her service and meaningful contributions to the Company over the past five years.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						PRIVIA HEALTH GROUP, INC.
Date: October 28, 2025						By:			/s/ Parth Mehrotra
									Name: Parth Mehrotra
									Title: Chief Executive Officer